Tag: Zepbound vials

In a move to improve accessibility, Eli Lilly introduced single-dose Zepbound vials, with discounted pricing made available through its direct-to-consumer platform, LillyDirect. This was a significant shift, especially for those without insurance coverage, and provides a clear answer to the question, 'How much will Zepbound vials cost?' by offering a more affordable option than the prefilled pens.

As of September 2025, the manufacturer Eli Lilly has made all FDA-approved doses of Zepbound (tirzepatide) available in both single-dose pens and single-dose vials. For patients wondering, 'Is Zepbound available in vials yet?', the answer is yes, offering a new, lower-cost self-pay option.